Cargando…
Is ambient assisted living the panacea for ageing population? /
| Clasificación: | Libro Electrónico |
|---|---|
| Autor Corporativo: | |
| Otros Autores: | , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Amsterdam ; Washingston, D.C. :
IOS Press,
©2013.
|
| Colección: | Ambient intelligence and smart environments ;
v. 16. |
| Temas: | |
| Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Title Page
- Foreword
- Acknowledgements
- Table of contents
- Background
- The Ageing of the European Population
- The Trivialisation of Technology
- The Role of DREAMING
- Concerns About AAL Technology Before DREAMING
- Ease of Use for Senior Citizens
- Reliability of the Platform
- Technology Aversion
- A Perceived Need for Passive Systems
- Effort and Cost of Installation and Maintenance
- "Care" and "Technology"
- Contradictory Terms?
- The Technology Platform
- Functional Requirements for the DREAMING Platform
- Health Monitoring
- Environmental Monitoring
- Mobile Alarm and Localization
- Videoconferencing
- Care Givers' Decision Support
- An Overview of the DREAMING Platform
- The HIS Telemonitoring System
- HIS Central Unit
- HIS Portal
- Vital Monitors
- Environmental Monitors
- Mobile Option
- ello! Videoconferencing System
- Scaling the DREAMING Platform
- Technology and Support
- The Evolution of Technology
- The DREAMING Platform in 2013
- The Central Unit
- The Smartphone or Tablet
- The Trial Sites
- Denmark
- Overview of Trial Site
- Estonia
- Overview of Trial Site
- Germany
- Overview of Trial Site
- Italy
- Overview of Trial Site
- Spain
- Overview of Trial Site
- Sweden
- Overview of Trial Site
- Equipment Installed
- DREAMING Clinical Trial Protocol According to the CONSORT Checklist Items
- Objectives
- Inclusion and Exclusion Criteria for Participants
- Interventions
- Interventions in the Intervention Group
- Interventions in the Control Group
- Sample Size
- Statistical Methods
- Information About the Trial Populations
- Recruitment of Users
- Denmark
- Estonia
- Germany
- Italy
- Spain
- Sweden
- Analysis of the User Population
- Denmark
- Estonia
- Germany
- Italy
- Spain
- Sweden
- The Outcome
- List of the Primary and Secondary Outcomes.
- Rationale for Clinical Impact Indicator Definition
- Health Status Questionnaire SF-36 v2
- HADS (Hospital Anxiety and Depression Scale)
- Full List of Clinical Impact (Outcome) Indicators Used in DREAMING
- Time Points and Methods of Outcome Assessment
- Analysis of the Primary and Secondary Outcomes
- SF-36 & HADS
- Overview
- SF-36 Consolidated Cross Site Analysis
- HADS
- Discussion
- Effect on Mental/Clinical Events
- Considerations & Limitations
- Initial Conclusions
- User Satisfaction
- Methodology
- Cross-Pilot Analysis and Results
- Conclusions and Lessons Learned
- Economic Impact
- Approach
- Economic Indicators
- Clinical Activity Indicators
- Services Tariffs
- Considerations
- Costs Elements
- Denmark
- Estonia
- Germany
- Italy
- Spain
- Sweden
- Overall Conclusions
- Lessons Learned
- Implementation Guidelines and Recommendations
- Objective of Service
- Prerequisites
- Selection of Participants
- Planning Installation
- Equipment Selection: Reliability, Evaluation and Certification
- Devices: Aim of Their Use, Training Users
- Monitoring and Handling Alarms
- What to Do in Case of Emergency
- The Contact Centre
- Empowerment of Older Participants and Role of Care Givers
- Professionals: Roles, Rules, Expertise
- Towards a New Integrated Home Care
- Customer Satisfaction Evaluation and Feedback
- Cost/Benefit Evaluation
- Lessons Learned
- General
- Organisational
- Selection of Citizens/Patient for Tele-Monitoring
- Service Reliability
- Equipment
- Medical Devices
- Market Analysis
- Market Segmentation
- Overview
- Sizing of the Market for DREAMING in the Participating Countries
- The Market for DREAMING in the EU
- User Advisory Group Feedback
- Main Conclusions
- Usability, Technology Acceptance
- Technology Performance, Installation and Maintenance.
- Workforce and Service Organization
- Sustainability and Wide Deployment
- Main Recommendations
- Further Research and Data
- Business Case
- New Technology Components
- Conclusions
- Appendix A
- Questionnaires
- SF-36
- Hospital Anxiety Depression Scale (HADS)
- Appendix B
- Glossary.